Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
76
XHR Quote, Financials, Valuation and Earnings
Last price:
$12.23
Seasonality move
:
-5.42%
Day range:
$12.03 - $12.32
52-week range:
$8.55 - $16.50
Dividend yield:
4.09%
P/E ratio:
55.89x
P/S ratio:
1.17x
P/B ratio:
1.00x
Volume:
1M
Avg. volume:
924.7K
1-year change:
-13.63%
Market cap:
$1.2B
Revenue:
$1B
EPS (TTM):
$0.22
Analysts' Opinion
-
Consensus RatingXenia Hotels & Resorts has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.60, Xenia Hotels & Resorts has an estimated upside of 11.2% from its current price of $12.23.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $12.00 representing 1.88% downside risk from its current price of $12.23.
Fair Value
-
According to the consensus of 5 analysts, Xenia Hotels & Resorts has 11.2% upside to fair value with a price target of $13.60 per share.
XHR vs. S&P 500
-
Over the past 5 trading days, Xenia Hotels & Resorts has overperformed the S&P 500 by 2.95% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Xenia Hotels & Resorts does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Xenia Hotels & Resorts has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Xenia Hotels & Resorts reported revenues of $288.9M.
Earnings Growth
-
Xenia Hotels & Resorts has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Xenia Hotels & Resorts reported earnings per share of $0.15.
Enterprise value:
2.6B
EV / Invested capital:
0.96x
Price / LTM sales:
1.17x
EV / EBIT:
24.98x
EV / Revenue:
2.41x
PEG ratio (5yr expected):
3.68x
EV / Free cash flow:
47.12x
Price / Operating cash flow:
22.95x
Enterprise value / EBITDA:
11.01x
Gross Profit (TTM):
$261M
Return On Assets:
0.8%
Net Income Margin (TTM):
2.19%
Return On Equity:
1.8%
Return On Invested Capital:
0.87%
Operating Margin:
12.41%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1B | $1.1B | $267.5M | $288.9M | |
| Gross Profit | $297.3M | $261.8M | $261M | $70.2M | $78.8M | |
| Operating Income | $124.9M | $90.8M | $93.8M | $27.1M | $35.9M | |
| EBITDA | $295.6M | $232.7M | $232.4M | $62M | $71.6M | |
| Diluted EPS | $0.60 | $0.19 | $0.22 | $0.08 | $0.15 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $403.8M | $255.5M | $389.6M | $238.3M | $283.4M | |
| Total Assets | $3B | $3B | $3.1B | $2.9B | $2.9B | |
| Current Liabilities | $61.6M | $92.8M | $107.3M | $119M | $133.4M | |
| Total Liabilities | $1.5B | $1.6B | $1.6B | $1.6B | $1.6B | |
| Total Equity | $1.5B | $1.4B | $1.4B | $1.3B | $1.2B | |
| Total Debt | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $184.9M | $192.5M | $193.8M | $24.7M | $54.8M | |
| Cash From Investing | $25.1M | -$140.5M | -$132.2M | -$32.3M | -$56.2M | |
| Cash From Financing | -$87.9M | -$196.4M | -$76.5M | -$18.6M | $39.9M | |
| Free Cash Flow | $110.4M | $49.8M | $54.3M | -$8.7M | $22.4M | |
XHR
Sector
Market Cap
$1.2B
$1.1B
Price % of 52-Week High
74.12%
82.85%
Dividend Yield
4.09%
3.24%
Shareholder Yield
7.68%
4.07%
1-Year Price Total Return
-13.63%
--
Beta (5-Year)
1.598
0.768
Dividend yield:
4.09%
Annualized payout:
$0.48
Payout ratio:
215.34%
Growth streak:
2 years
Technicals
8-day SMA
Buy
Level
$11.92
200-day SMA
Sell
Level
$13.68
Bollinger Bands (100)
Sell
Level
10.96 - 14.46
Chaikin Money Flow
Buy
Level
42.4M
20-day SMA
Buy
Level
$11.87
Relative Strength Index (RSI14)
Buy
Level
61.86
ADX Line
Buy
Level
23.44
Williams %R
Neutral
Level
-25.8333
50-day SMA
Buy
Level
$11.23
MACD (12, 26)
Buy
Level
0.25
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Sell
Level
-4.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7455)
Sell
CA Score
(Annual)
Level (-0.442)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.4687)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The firm's customer groups include transient business, group business, and contract business.
Stock Forecast FAQ
In the current month, XHR has received 3 Buy ratings 2 Hold ratings, and 0 Sell ratings. The XHR average analyst price target in the past 3 months is $13.60.
-
Where Will Xenia Hotels & Resorts Stock Be In 1 Year?
According to analysts, the consensus estimate is that Xenia Hotels & Resorts share price will rise to $13.60 per share over the next 12 months.
-
What Do Analysts Say About Xenia Hotels & Resorts?
Analysts are divided on their view about Xenia Hotels & Resorts share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Xenia Hotels & Resorts is a Sell and believe this share price will drop from its current level to $12.00.
-
What Is Xenia Hotels & Resorts's Price Target?
The price target for Xenia Hotels & Resorts over the next 1-year time period is forecast to be $13.60 according to 5 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is XHR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Xenia Hotels & Resorts is a Buy. 3 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of XHR?
You can purchase shares of Xenia Hotels & Resorts via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Xenia Hotels & Resorts shares.
-
What Is The Xenia Hotels & Resorts Share Price Today?
Xenia Hotels & Resorts was last trading at $12.23 per share. This represents the most recent stock quote for Xenia Hotels & Resorts. Yesterday, Xenia Hotels & Resorts closed at $12.23 per share.
-
How To Buy Xenia Hotels & Resorts Stock Online?
In order to purchase Xenia Hotels & Resorts stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
